Evidence map›Paper›PMID 29569852›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2018

Editorial: Toward Personalized Treatment for Systemic Juvenile Idiopathic Arthritis.

Sebastiaan J Vastert, Peter A Nigrovic

Abstract readEditorialComment
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Sebastiaan J VastertUniversity Medical Center Utrecht, Utrecht, The Netherlands.
Peter A NigrovicBrigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.

Funding

Joint Biology Consortium Resource-based CenterP30AR070253 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Peter A Nigrovic, Jeffrey Andrew Sparks · 2016 to 2026
$9.4M
Ly6 family members in neutrophil biologyR01AR065538 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI NIGROVIC, PETER A · 2014 to 2024
$4.0M
NIAMS NIH HHS P30 AR070253NIAMS NIH HHS R01 AR065538
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Arthritis, JuvenileDisease SusceptibilityHumansImmunosuppressive AgentsInterleukin 1 Receptor Antagonist ProteinReceptors, Interleukin-1IL1RN protein, humanImmunosuppressive AgentsInterleukin 1 Receptor Antagonist ProteinReceptors, Interleukin-1

Identifiers

PMID29569852
PMCPMC6105394

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.